Sanofi Aktie
98,42
EUR
-0,42
EUR
-0,42
%
98,36
EUR
+1,35
EUR
+1,39
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 105,00 EUR | +6,75% | 16.01.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 115,00 EUR | +16,92% | 07.01.2025 | |
| Bernstein Research | 114,00 EUR | +15,90% | 07.01.2025 | |
| Deutsche Bank AG | 85,00 EUR | -13,58% | 18.12.2024 | |
| Jefferies & Company Inc. | 120,00 EUR | +22,00% | 17.12.2024 | |
| DZ BANK | - | - | 28.10.2024 | |
| UBS AG | 110,00 EUR | +11,83% | 28.10.2024 | |
| Barclays Capital | 120,00 EUR | +22,00% | 23.09.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 4 | 0 | 138,37 GBP | +26,50% |
| Bayer | 1 | 8 | 0 | 24,12 EUR | +14,20% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,50 USD | +21,95% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | +20,70% |
| GSK PLC Registered Shs | 2 | 6 | 1 | 16,77 GBP | +23,40% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 184,00 EUR | +29,26% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +97,68% |
| MorphoSys | 1 | 2 | 0 | 41,33 EUR | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 98,86 CHF | +10,68% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 31,20 USD | +18,63% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +11,69% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |